Identification of 5-hydroxytryptamine1D binding sites in sheep caudate nucleus membranes

doi:10.1016/0006-2952(93)90531-Z

Biochemical Pharmacology

Volume 46, Issue 3, 3 August 1993, Pages 535-538

https://doi.org/10.1016/0006-2952(93)90531-Z Get rights and content

Abstract

Radioligand binding measurements were performed in membranes of sheep caudate nucleus using [³H]5-hydroxytryptamine (5-HT). [³H]5-HT labeled a population of high affinity binding sites with a K_d of 1.9 ± 0.1 nM and a B_{max of} 19.8 ± 2.2 mol/mg tissue. Combined 5-HT_1D/E binding sites were the predominant 5-HT₁ subtype, accounting for 78% of the total population of 5-HT₁, binding sites. 5-Carboxamidotryptamine (5-CT) and sumatriptan yielded inhibition curves which best fitted a two-site model with high affinity values of 0.8 and 10.1 nM, and 1000 and 206 nM for their low affinity components. The proportion of the high affinity 5-CT and sumatriptan binding sites was 79 and 72%. The binding affinity profile of 5-HT_1D binding sites [5-CT > 5-HT > d-LSD > 5-MeOT > sumatriptan > RU 24, 969 > metergoline > tryptamine = rauwolscine = methylsergide > yohimbine = methiothepin > TFMPP = 8-OH-DPAT > 2-methyl-5-HT > mCPP = quipazine = CP 93, 129 > ketanserin > (-)-propranolol = haloperidol = ipsapirone]compares well to that reported for 5-HT_1D receptor sites in human caudate and cortex (correlation coefficient: 0.99 and 0.98). The present results indicate that sheep caudate nucleus is a valid tissue for studying interaction of compounds with 5-HT_1D binding sites in the relative absence of 5-HT_1E binding sites.

References (15)

C Mahle et al.
³H-5-Carboxamidotryptamine labels multiple high affinity 5-HT_1D-like sites in guinea-pig brain
Eur J Pharmacol
(1991)
SJ Peroutka
Cortical and striatal variations in drug competition studies with putative 5-HT_1D binding sites
Brain Res
(1991)
MS Beer et al.
An investigation of the 5-HT_1D receptor binding affinity of 5-hydroxytryptamine, 5-carboxamidotryptamine and sumatriptan in the central nervous system of seven species
Eur J Pharmacol
(1992)
PJ Munson et al.
Ligand: a versatile computerized approach for the characterization of ligand binding systems
Anal Biochem
(1980)
PJ Pauwels et al.
Activity of 5-HT receptor agonist, partial agonists and antagonists at cloned human 5-HT_1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells
Biochem Pharmacol
(1993)
S Lowther et al.
The distribution of 5-HT_1D and 5-HT_1E binding sites in human brain
Eur J Pharmacol
(1992)
KJ Miller et al.
Quantitative autoradiography of 5-CT-sensitive (5-HT_1D) and 5-CT-insensitive (5-HT_1E) serotonin receptors in human brain
Neurosci Lett
(1992)

There are more references available in the full text version of this article.

Cited by (4)

Cortical serotonin<inf>7, 1D</inf> and <inf>1F</inf> receptors: Effects of schizophrenia, suicide and antipsychotic drug treatment
2006, Schizophrenia Research
Abnormalities in serotonergic function are thought to be important in the pathology of schizophrenia. Postmortem CNS studies suggest that levels of serotonin receptors may be altered in the cortex of subjects with schizophrenia. Seeking to expand this hypothesis we have examined the effect of schizophrenia and antipsychotic drug treatments on the levels of cortical serotonin₇, _1D and _1F receptors. There was a significant decrease in the binding of [³H]SB 269970 to the serotonin₇ receptor in Brodmann's area 9 from subjects with schizophrenia compared to controls (Mean ± S.E.M.: 8.3 ± 0.76 vs. 11.0 ± 0.64 fmol/mg ETE; p < 0.05) and an increase in the binding of that radioligand in the cortex of rats treated with haloperidol (p = 0.03). There were no significant differences in [³H]sumatriptan binding to the serotonin_1D or serotonin_1F receptor in Brodmann's area 9 from subjects with schizophrenia. There was a significant increase in [³H]sumatriptan binding to the serotonin_1D in binding Layer 2 from subjects who had potentially died by suicide that was not present in other binding layers or for the serotonin_1F or serotonin₇ receptors. There was decrease in [³H]sumatriptan binding to the serotonin_1D, but not serotonin_1F, receptors across all cortical binding layers in rats treated with haloperidol. These data would be consistent with the hypothesis that decreased levels of serotonin₇ receptors in Brodmann's area 9 may be involved in the pathological processes of schizophrenia and that levels of cortical serotonin₇ and _1D receptors can be affected by antipsychotic drug treatment.
Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM
2003, Pharmacology Biochemistry and Behavior
The present investigation was undertaken to test the hypothesis that known metabolites of the phenylethylamine hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) are pharmacologically active. This hypothesis was tested by evaluating the ability of racemic DOM metabolites 2-O-desmethyl DOM (2-DM-DOM) and 5-O-desmethyl DOM (5-DM-DOM) to substitute for the stimulus properties of (+)lysergic acid diethylamide (LSD). The data indicate that both metabolites are active in LSD-trained subjects and are significantly inhibited by the selective 5-HT_2A receptor antagonist M100907. Full generalization of LSD to both 2-DM-DOM and 5-DM-DOM occurred, and 5-DM-DOM was slightly more potent than 2-DM-DOM. Similarly, 5-DM-DOM had a slightly higher affinity than 2-DM-DOM for both 5-HT_2A and 5-HT_2C receptors. Additionally, it was of interest to determine if the formation of active metabolite(s) resulted in a temporal delay associated with maximal stimulus effects of DOM. We postulated that if metabolite formation resulted in the aforementioned delay, direct administration of the metabolites might result in maximally stable stimulus effects at an earlier pretreatment time. This hypothesis was tested by evaluating (1) the time point at which DOM produces the greatest degree of LSD-appropriate responding, (2) the involvement of 5-HT_2A receptor in the stimulus effects of DOM at various pretreatment times by administration of M100907 and (3) the ability of 2-DM-DOM and 5-DM-DOM to substitute for the stimulus properties of LSD using either 15- or 75-min pretreatment time. The data indicate that (a) the DOM stimulus produces the greatest degree of LSD-appropriate responding at the 75-min time point in comparison with earlier pretreatment times and (b) the stimulus effects of DOM are differentially antagonized by M100907 and this effect is a function of DOM pretreatment time prior to testing. Both 2-DM-DOM and 5-DM-DOM were found to be most active, at all doses tested, using a 75-min versus a 15-min pretreatment time. The present data do not permit unequivocal acceptance or rejection of the hypothesis that active metabolites of (−)-DOM provide a full explanation of the observed discrepancy between brain levels of (−)-DOM and maximal stimulus effects.
Inhibition by 5-HT of forskolin-induced cAMP Formation in the renal opossum Epithelial cell line OK: Mediation by a 5-HT<inf>1B</inf> like receptor and antagonism by methiothepin
1994, Neuropharmacology
The functional activity of various 5-HT receptor agonists, including 5-CT, sumatriptan, CP 93, 129 and 1-naphtylpiperazine, and of drugs known to bind with high affinity to 5-HT_1B (pindolol, propranolol, cyanopindolol, SDZ 21,009 and isamoltane) or 5-HT_1D binding sites (yohimbine and rauwolscine) was measured at 5-HT receptors that are negatively coupled to adenylate cyclase in cultures of the renal epithelial cell line OK. 5-HT receptor-mediated inhibition of adenylate cyclase was studied by measuring inhibition of cAMP formation, induced by 100 μM forskolin. Besides 5-HT, various other compounds with affinity for 5-HT receptors behaved as agonists with the following rank order of potency: RU 24,969 > 5-CT > dihydroergotamine = 5-HT > CP 93,129 > d-LSD > 1-naphtylpiperazine > sumatriptan > TFMPP = mCPP > CGS 12066B = metergoline > methysergide. The β-adrenergic receptor blockers cyanopindolol, SDZ 21,009, (−)-pindolol and (−)-propranolol, and the α₂-adrenergic blockers yohimbine and rauwolscine yielded agonist activity at nanomolar and micromolar concentrations, respectively. Isamoltane acted as a partial agonist. Methiothepin was the only compound that antagonised the OK cell 5-HT receptor-mediated inhibition of forskolin-induced cAMP formation. We conclude that the OK cell 5-HT receptor has properties consistent with a 5-HT_1B receptor, although differences are apparent with regard to potencies of some compounds. Methiothepin is probably the only effective antagonist at 5-HT_1B receptor sites, whereas the described putative 5-HT_1B receptor antagonists have to be considered as partial agonists, yielding agonist or antagonist activity depending on the system that is studied.
F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT(1B/1D) receptors in models relevant to migraine
1999, Journal of Pharmacology and Experimental Therapeutics

View full text

Short communicationIdentification of 5-hydroxytryptamine1D binding sites in sheep caudate nucleus membranes

Abstract

Eur J Pharmacol

Brain Res

Eur J Pharmacol

Anal Biochem

Biochem Pharmacol

Eur J Pharmacol

Neurosci Lett

Short communication
Identification of 5-hydroxytryptamine_1D binding sites in sheep caudate nucleus membranes